Yatharth Hospit.

Which are the latest news on Yatharth Hospit.?

Why is Yatharth Hospital & Trauma Care Services Ltd falling/rising?

As of 05-Sep, Yatharth Hospital & Trauma Care Services Ltd's stock price has risen to Rs 990.60, up 2.89%, driven by strong financial performance and positive market trends. The stock has significantly outperformed the Sensex and is close to its 52-week high, indicating optimistic investor sentiment.

As of 05-Sep, Yatharth Hospital & Trauma Care Services Ltd is experiencing a rise in its stock price, currently at Rs 990.60, reflecting an increase of Rs 27.85 or 2.89%. This upward movement can be attributed to several positive factors. The stock has shown strong performance over various time periods, with a year-to-date increase of 45.35%, significantly outperforming the Sensex, which has declined by 10.21% in the same timeframe. Additionally, the stock has gained 17.12% over the past month, while the benchmark has fallen by 2.44%.<BR><BR>Today's performance is particularly noteworthy as the stock has outperformed its sector by 4.2% and has reversed a trend of three consecutive days of decline. It is also trading above its moving averages across multiple time frames, indicating a strong bullish trend. Furthermore, the company has maintained a net-debt-free status and has reported positive financial results for the last 12 consecutive quarters, with a notable growth in profit after tax and net sales.<BR><BR>Despite a significant drop in investor participation, as evidenced by a 77.21% decrease in delivery volume compared to the 5-day average, the stock remains liquid enough for trading. The proximity to its 52-week high, being only 3.42% away from Rs 1024.95, also suggests that investor sentiment remains optimistic. Overall, the combination of strong financial performance, consistent returns, and positive market trends contributes to the rising stock price of Yatharth Hospital & Trauma Care Services Ltd.

Who are in the management team of Yatharth Hospit.?

The management team of Yatharth Hospital includes Ajay Kumar Tyagi (Chairman & Wholetime Director), Kapil Kumar (Managing Director), Yatharth Tyagi (Whole-time Director), and three Independent Directors: Mukesh Sharma, Sanjeev Upadhyaya, and Promila Bhardwaj, along with Ritesh Mishra (Company Secretary & Compliance Officer).

The management team of Yatharth Hospital includes the following individuals:<BR><BR>1. **Ajay Kumar Tyagi** - Chairman & Wholetime Director<BR>2. **Kapil Kumar** - Managing Director<BR>3. **Yatharth Tyagi** - Whole-time Director<BR>4. **Mukesh Sharma** - Independent Director<BR>5. **Sanjeev Upadhyaya** - Independent Director<BR>6. **Promila Bhardwaj** - Independent Director<BR>7. **Ritesh Mishra** - Company Secretary & Compliance Officer<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

What does Yatharth Hospit. do?

Yatharth Hospital & Trauma Care Services Ltd is a small-cap company in the hospital industry, incorporated in 2008 and transitioned to a public company in 2021. As of June 2026, it reported net sales of ₹393 Cr and a net profit of ₹47 Cr, with a market cap of ₹9,340 Cr.

Overview:<BR>Yatharth Hospital & Trauma Care Services Ltd operates in the hospital industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated as a Private Limited Company in Delhi in 2008, transitioned to a Public Company on November 3, 2021, and changed its name to Yatharth Hospital & Trauma Care Services Limited on November 18, 2021. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 393 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 47 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 9,340 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 53.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.05% <BR>Debt Equity: 0.00 <BR>Return on Equity: 9.89% <BR>Price to Book: 5.21 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Yatharth Hospit.?

Yatharth Hospital's peers include Dr Agarwal's Health, Rainbow Children, Health.Global, Jupiter Life Line, Kovai Medical, Jeena Sikho, Artemis Medicare, Indraprastha Medical, and Dr Agarwal's Eye. Yatharth Hospital has below-average management risk and average growth, with a 1-year return of 44.15%, outperforming most peers.

Peers: The peers of Yatharth Hospit. are Dr Agarwal's Hea, Rainbow Child., Health.Global, Jupiter Life Lin, Kovai Medical, Jeena Sikho, Artemis Medicare, Indrapr.Medical, and Dr Agarwal's Eye.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jupiter Life Lin, Jeena Sikho, and Kovai Medical, while Average management risk is found at Dr Agarwal's Hea, Health.Global, Artemis Medicare, Indrapr.Medical, and Dr Agarwal's Eye. Below Average management risk is associated with Yatharth Hospit. Growth is Excellent at Jeena Sikho, Good at Dr Agarwal's Hea, Health.Global, Jupiter Life Lin, Artemis Medicare, and Indrapr.Medical, while Average growth is seen at Yatharth Hospit. and Below Average growth at Rainbow Child., Kovai Medical, and Jeena Sikho. Capital Structure is Excellent at Jupiter Life Lin, Jeena Sikho, and Indrapr.Medical, Good at Dr Agarwal's Hea, Rainbow Child., Kovai Medical, Artemis Medicare, and Average at Dr Agarwal's Eye.<BR><BR>Return Snapshot: Yatharth Hospit. has a 1-year return of 44.15%, while the highest return is from Dr Agarwal's Hea at 18.31% and the lowest is from Jeena Sikho at -27.85%. Additionally, Health.Global, Jeena Sikho, Indrapr.Medical, and Rainbow Child. have negative six-month returns.

How big is Yatharth Hospit.?

As of 31st August, Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of 9,340.00 Cr, with recent Net Sales of 1,334.10 Cr and a Net Profit of 181.17 Cr.

As of 31st August, Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of 9,340.00 Cr, categorizing it as a Small Cap company.<BR><BR>For the latest four quarters, Yatharth Hospital reported Net Sales of 1,334.10 Cr and a Net Profit of 181.17 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 1,605.46 Cr and Total Assets of 1,713.06 Cr.

Should I buy, sell or hold Yatharth Hospital & Trauma Care Services Ltd?

Has Yatharth Hospital & Trauma Care Services Ltd declared dividend?

Yes, Yatharth Hospital & Trauma Care Services Ltd has declared a 5% dividend, with an ex-date of August 14, 2026. Despite this, the dividend yield is 0%, while total returns over various periods show strong price performance.

Yatharth Hospital & Trauma Care Services Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Ex-date: 14 Aug 26<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 3 months, the price return was 6.03%, the dividend return was 0.06%, resulting in a total return of 6.09%.<BR><BR>Over the past 6 months, the price return was 24.89%, the dividend return was 0.07%, leading to a total return of 24.96%.<BR><BR>In the last year, the price return was 22.15%, with a dividend return of 0.07%, culminating in a total return of 22.22%.<BR><BR>For the 2-year period, the price return was 90.13%, the dividend return was 0.10%, which resulted in a total return of 90.23%.<BR><BR>During the 3-year period, the price return was 162.34%, the dividend return was 0.13%, leading to a total return of 162.47%.<BR><BR>In the 4-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>For the 5-year period, the price return was 0% and the dividend return was also 0%, leading to a total return of 0.0%.<BR><BR>Overall, Yatharth Hospital & Trauma Care Services Ltd has declared a dividend, although the dividend yield remains at 0%. The total returns over various periods indicate a strong performance in price returns, particularly over longer durations, despite minimal contributions from dividends.

When is the next results date for Yatharth Hospital & Trauma Care Services Ltd?

The next results date for Yatharth Hospital & Trauma Care Services Ltd is August 10, 2026.

The next results date for Yatharth Hospital & Trauma Care Services Ltd is scheduled for August 10, 2026.

Are Yatharth Hospital & Trauma Care Services Ltd latest results good or bad?

Yatharth Hospital & Trauma Care Services Ltd's latest results show strong revenue growth with Q4 FY26 revenues up 47.36% year-on-year, but declining PAT margins to 13.09% raise concerns about sustainability. Overall, the results are mixed, indicating robust growth alongside operational challenges.

Yatharth Hospital & Trauma Care Services Ltd's latest results present a mixed picture. On one hand, the company has shown impressive revenue growth, with Q4 FY26 revenues reaching ₹341.56 crores, marking a 6.58% increase quarter-on-quarter and a remarkable 47.36% increase year-on-year. The net profit for the same quarter was ₹47.52 crores, reflecting a 4.79% rise from the previous quarter and a 22.73% increase year-on-year.<BR><BR>However, there are concerns regarding margin pressures. The PAT margin has declined to 13.09%, down from 16.71% in Q4 FY25, indicating a significant compression of 362 basis points. This decline in profitability metrics raises questions about the sustainability of the company's growth, especially as it continues to expand aggressively.<BR><BR>Overall, while the revenue and profit figures are strong and indicate robust growth, the declining margins suggest that the company is facing operational challenges that investors should monitor closely.

How has been the historical performance of Yatharth Hospit.?

Yatharth Hospital has shown significant growth from March 2022 to March 2025, with net sales increasing from 400.94 crore to 880.49 crore, and profit after tax rising from 44.16 crore to 130.55 crore, alongside a substantial improvement in total assets and cash flow. Overall, the hospital has demonstrated robust revenue and profitability growth during this period.

Answer:<BR>The historical performance of Yatharth Hospital shows significant growth in various financial metrics over the past few years.<BR><BR>Breakdown:<BR>Yatharth Hospital's net sales have increased from 400.94 crore in March 2022 to 880.49 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 400.94 crore in March 2022 to 880.49 crore in March 2025. The total expenditure, excluding depreciation, also grew from 290.13 crore in March 2022 to 660.30 crore in March 2025, indicating increased operational costs. Operating profit (PBDIT) has seen a notable increase, climbing from 110.81 crore in March 2022 to 236.37 crore in March 2025. Profit before tax rose from 63.11 crore in March 2022 to 171.74 crore in March 2025, while profit after tax increased from 44.16 crore to 130.55 crore in the same period. The company's total assets have surged from 420.57 crore in March 2022 to 1,713.06 crore in March 2025, with total liabilities also rising from 420.57 crore to 1,713.06 crore. Cash flow from operating activities improved significantly, moving from 59 crore in March 2022 to 149 crore in March 2025, contributing to a net cash inflow of 248 crore in March 2025, up from 6 crore in March 2022. Overall, Yatharth Hospital has demonstrated robust growth in revenue, profitability, and asset base over the past few years.

Is Yatharth Hospit. technically bullish or bearish?

As of November 3, 2025, Yatharth Hospital's technical trend is mildly bullish, supported by a bullish MACD and moving averages, though caution is advised due to a mildly bearish KST and lack of momentum in the RSI.

As of 3 November 2025, the technical trend for Yatharth Hospital has changed from bullish to mildly bullish. The weekly MACD remains bullish, supported by bullish signals from the Bollinger Bands on both weekly and monthly time frames. The daily moving averages also indicate a bullish stance. However, the KST on a weekly basis is mildly bearish, suggesting some caution. The RSI shows no signal on both weekly and monthly charts, indicating a lack of momentum. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and moving averages, despite some mixed signals from other indicators.

Is Yatharth Hospit. overvalued or undervalued?

As of October 8, 2025, Yatharth Hospital is considered very expensive and overvalued, with a PE ratio of 56.35, an EV to EBITDA of 32.50, and a Price to Book Value of 4.99, despite having a lower PE ratio than peers like Max Healthcare and Fortis Healthcare, while significantly outperforming the Sensex with a year-to-date return of 46.93%.

As of 8 October 2025, the valuation grade for Yatharth Hospital has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 56.35, an EV to EBITDA of 32.50, and a Price to Book Value of 4.99, all of which suggest a high valuation relative to earnings and book value.<BR><BR>In comparison to its peers, Yatharth Hospital's PE ratio is lower than that of Max Healthcare at 92.31 and Fortis Healthcare at 86.26, both of which are also categorized as very expensive. However, it is notably higher than Narayana Hrudaya, which has a PE of 46.14 and is classified as expensive. The recent stock performance has outpaced the Sensex, with a year-to-date return of 46.93% compared to the Sensex's 4.65%, reinforcing the notion that the stock is currently overvalued in the market.

Who are the top shareholders of the Yatharth Hospit.?

The top shareholders of Yatharth Hospital include promoter Ajay Kumar Tyagi with 30.59%, mutual funds holding 9.42%, foreign institutional investors at 4.45%, and individual investors with 14.87%. The largest public shareholder is Kotak Mahindra Trustee Co Ltd, representing the Kotak Multicap Fund, with 4.36%.

The top shareholders of Yatharth Hospital include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ajay Kumar Tyagi, with a significant stake of 30.59%. Additionally, mutual funds hold 9.42% of the shares through 8 schemes, while foreign institutional investors (FIIs) account for 4.45% with 30 different FIIs involved. The highest public shareholder is Kotak Mahindra Trustee Co Ltd, representing the Kotak Multicap Fund, which holds 4.36%. Individual investors collectively hold 14.87% of the company's shares.